Cancer Clinical Trials
Complete Clinical Trial List
Clinical trials are research studies that evaluate new procedures or drugs, weighing their effectiveness against current, standard protocols. BIDMC investigators studying cancer help "translate" their laboratory discoveries into clinical trials that eventually lead to improved treatments that benefit patients here and elsewhere.
Our specialty programs participate in a wide range of Phase I through Phase IV studies that investigate new uses of FDA approved drugs as well as novel investigational agents. Because the Cancer Center at BIDMC is part of a full service hospital, patients enrolled in clinical trials receive cohesive, patient-focused, comprehensive care.
What Are the Benefits of Participating?
The Cancer Center's acclaimed clinical researchers offer patients novel treatment options through a number of clinical trials. Through these special research studies, patients can access new, potentially more effective treatment options before they become more widely available.
Our patients benefit from BIDMC's membership in the Dana-Farber/Harvard Cancer Center, the largest cancer research consortium in the country. This provides them with access to a broad array of the most current clinical trials.
BIDMC physician-scientists participate in some 140 clinical trials in connection with:
The Cancer Clinical Trials Office
The Cancer Clinical Trials Office (CCTO) at BIDMC supports clinical research in all cancer-related programs.
The CCTO coordinates with the BIDMC Institutional Review Board (IRB), a governing body that oversees the safety and integrity of clinical trials. On behalf of Cancer Center investigators, the CCTO submits to the IRB new protocols, protocol annual continuing reviews, protocol and consent form amendments and treatment toxicity and efficacy information in compliance with local and federal regulations. Routine self and external audits are conducted to ensure protocol compliance and quality, patient safety, and to promote continued staff education.
For information about cancer-related clinical trials at BIDMC, please call the CCTO at 617-667-3060.
What Clinical Trials Are Available?
Click the links below for listings of active and enrolling cancer-related clinical trials at BIDMC, by specialty area.
Phase 1 Trials
Colon and Rectal Cancer
Head and Neck Cancer
Hematologic Malignancies / Bone Marrow Transplant
Thoracic / Lung Cancer
Melanoma / Cutaneous Cancer
Thyroid / Endocrine Cancer